Individualised aging therapeutics for all

Building an AI-driven multiomics aging drug platform to decode aging cell by cell

Precision drug optimisation at the individual level

AgeCurve is building advanced aging diagnostics and therapeutics tools by combining somatic genotype with cellular phenotype on the single cell level and applying a full machine learning and AI stack.

Please see our study publiched in Geroscience: Cell Tree Rings: the structure of somatic evolution as a human aging timer

View study

Board

Attila Csordas, PhD

CEO/Founder

Petr Sramek

Investor

Matthew Clevely

Business

Advisers

Issac Emmanuel Kai'en Goh, PhD

Science, AI

Karoly Nikolich, PhD

Strategy

Fiona Nielsen

Business

Allart Stoop, PhD

Immunology

Professor Damien G. Hicks

Science

Investors

Partners